Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Despite aggressive medical and nutritional management, patients with methylmalonic acidemia (MMA) often suffer from multi-organ damage. Early deceased donor liver transplantation (DDLT) has emerged as an intervention to prevent disease progression. We investigated the efficacy of living donor LT (LDLT) with a potential carrier of MMA and a small volume of graft in patients with MMA as an alternative to DDLT. Methods: Of five patients (three male, two female; median age 5.7 years; range, 1.3–13.7 years), four underwent carrier LDLT, while one underwent non-carrier auxiliary LDLT. All patients received pre- and post-LT continuous renal replacement therapy and were provided with minimal restriction diet according to serum MMA level after LT. MMA levels in the serum and urine, the incidence of metabolic crisis, and clinical findings before and after LT were compared. Results: The survival rate was 100% during 2.2 years of follow up period after LT. In all five cases, MMA titer in the serum after transplantation decreased with less restrictive diet. Metabolic crisis was not observed during the follow-up period. In addition, no patient showed progression of severe renal impairment requiring hemodialysis. Progression of delayed cognitive development was not observed. Social functioning with improved neuropsychiatric development was observed. Conclusion: This study showed that LDLT achieved improved quality of life with less restrictive diet, therefore it could be a feasible alternative option to DDLT for the treatment of patients with MMA, even with an auxiliary LT.
Abstract
Purpose: Despite aggressive medical and nutritional management, patients with methylmalonic acidemia (MMA) often suffer from multi-organ damage. Early deceased donor liver transplantation (DDLT) has emerged as an intervention to prevent disease progression. We investigated the efficacy of living donor LT (LDLT) with a potential carrier of MMA and a small volume of graft in patients with MMA as an alternative to DDLT. Methods: Of five patients (three male, two female; median age 5.7 years; range, 1.3–13.7 years), four underwent carrier LDLT, while one underwent non-carrier auxiliary LDLT. All patients received pre- and post-LT continuous renal replacement therapy and were provided with minimal restriction diet according to serum MMA level after LT. MMA levels in the serum and urine, the incidence of metabolic crisis, and clinical findings before and after LT were compared. Results: The survival rate was 100% during 2.2 years of follow up period after LT. In all five cases, MMA titer in the serum after transplantation decreased with less restrictive diet. Metabolic crisis was not observed during the follow-up period. In addition, no patient showed progression of severe renal impairment requiring hemodialysis. Progression of delayed cognitive development was not observed. Social functioning with improved neuropsychiatric development was observed. Conclusion: This study showed that LDLT achieved improved quality of life with less restrictive diet, therefore it could be a feasible alternative option to DDLT for the treatment of patients with MMA, even with an auxiliary LT.
참고문헌 (12)
- Baumgartner MR, "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia", Orphanet J Rare Dis, 9, pp.130~ (2014)
- Fowler B, "Causes of and diagnostic approach to methylmalonic acidurias", J Inherit Metab Dis, 31, pp.350~360 (2008)
- Hörster F, "Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB)", Pediatr Res, 62, pp.225~230 (2007)
- Oishi K, "Liver transplantation for pediatric inherited metabolic disorders: considerations for indications, complications, and perioperative management", Pediatr Transplant, 20, pp.756~769 (2016)
- 김준석, "Liver Transplantation for Metabolic Liver Disease: Experience at a Living Donor Dominant Liver Transplantation Center", Pediatric Gastroenterology, Hepatology & Nutrition, 18(1), pp.48~54 (2015), 대한소아소화기영양학회
- Mazariegos G, "Liver transplantation for pediatric metabolic disease", Mol Genet Metab, 111, pp.418~427 (2014)
- McDiarmid SV, "Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation", Transplantation, 74, pp.173~181 (2002)
- Malinchoc M, "A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts", Hepatology, 31, pp.864~871 (2000)
- Morioka D, "Efficacy of living donor liver transplantation for patients with methylmalonic acidemia", Am J Transplant, 7, pp.2782~2787 (2007)
- Nicolaides P, "Neurological outcome of methylmalonic acidaemia", Arch Dis Child, 78, pp.508~512 (1998)
- Ledley FD, "Mapping of human methylmalonyl CoA mutase(MUT)locus on chromosome 6", Am J Hum Genet, 42, pp.839~846 (1988)
- Porta F, "Differential intraoperative effect of liver transplant in different inborn errors of metabolism", J Pediatr Gastroenterol Nutr, 69, pp.160~162 (2019)